1 resultado para 64-481

em eResearch Archive - Queensland Department of Agriculture


Relevância:

20.00% 20.00%

Publicador:

Resumo:

Despite an abundance of polyembryonic genotypes and the need for rootstocks that improve scion yield and productivity, simultaneous field testing of a wide range of mango (Mangifera indica L.) genotypes as rootstocks has not previously been reported. In this experiment, we examined the growth and yield of 'Kensington Pride' on 64 mango genotypes of diverse origin during the first four seasons of fruit production to identify those worth longer-term assessment. We also recorded morphological characteristics of seedlings of 46 of these genotypes in an attempt to relate these measures to subsequent field performance. Tree canopy development on the most vigorous rootstocks was almost double that on the least vigorous. Growth rates differed by more than 160%. Cumulative marketable yield ranged from 36 kg/tree for the lowest yielding rootstock to 181 kg/tree for the most productive. Yield efficiency also differed markedly among the 64 rootstocks with the best treatment being 3.5 times more efficient than the poorest treatment. No relationship was found between yield efficiency and tree size, suggesting it is possible to select highly efficient rootstocks of differing vigor. Two genotypes ('Brodie' and 'MYP') stood out as providing high yield efficiency with small tree size. A further two genotypes ('B' and 'Watertank') were identified as offering high yield efficiency and large tree size and should provide high early yields at traditional tree spacing. Efforts to relate the morphology of different genotype seedlings to subsequent performance as a rootstock showed that nursery performance of mango seedlings is no indication of their likely behavior as a rootstock. The economic cost of poor yields and low yield efficiencies during the early years of commercial orchard production provide a rationale for culling many of the rootstock treatments in this experiment and concentrating future assessment on the top ~20% of the 64 treatments. Of these, 'MYP', 'B', 'Watertank', 'Manzano', and 'Pancho' currently show the most promise.